| BRXVX | FSGEX | BRXVX / FSGEX | |
| Total Expense Ratio | 0.43 | 0.01 | 4,300% |
| Annual Report Gross Expense Ratio | 0.44 | 0.01 | 4,400% |
| Fund Existence | 10 years | 16 years | - |
| Gain YTD | 34.544 | 29.337 | 118% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.43B | 62.1B | 4% |
| Annual Yield % from dividends | 2.53 | 2.31 | 110% |
| Returns for 1 year | 33.82 | 28.43 | 119% |
| Returns for 3 years | 69.50 | 57.06 | 122% |
| Returns for 5 years | 58.58 | 45.49 | 129% |
| Returns for 10 years | 109.41 | 104.23 | 105% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SSEAX | 12.32 | 0.03 | +0.24% |
| SEI Screened World Equity Ex-US A (SIIT) | |||
| SUSYX | 13.32 | N/A | N/A |
| SEI US Managed Volatility Y (SIMT) | |||
| SXPRX | 54.76 | -0.02 | -0.04% |
| DWS S&P 500 Index R6 | |||
| FLIAX | 9.84 | -0.01 | -0.10% |
| First Sentier American Listed Infras I | |||
| JFNSX | 77.09 | -0.19 | -0.25% |
| Janus Henderson Global Life Sciences S | |||